Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Refchem:203201
2. Axelopran
3. 949904-48-7
4. 85u7rob149
5. 3-((1r,3r,5s)-8-(2-(cyclohexylmethyl((2s)-2,3-dihydroxypropanoyl)amino(ethyl)-8-azabicyclo(3.2.1)octan-3-yl(benzamide
6. Benzamide, 3-((3-endo)-8-(2-((cyclohexylmethyl)((2s)-2,3-dihydroxy-1-oxopropyl)amino)ethyl)-8-azabicyclo(3.2.1)oct-3-yl)-
7. 3-((1r,3r,5s)-8-(2-((s)-n-(cyclohexylmethyl)-2,3-dihydroxypropanamido)ethyl)-8-azabicyclo[3.2.1]octan-3-yl)benzamide
8. Axelopran [usan:inn]
9. Unii-85u7rob149
10. Axelopran [inn]
11. Td 1211
12. Axelopran [usan]
13. Axelopran [who-dd]
14. Orb1698254
15. Schembl1773801
16. Schembl1773803
17. Schembl1773972
18. Chembl3137313
19. Schembl31495871
20. Dtxsid301032386
21. Glxc-15726
22. Bdbm50529499
23. Nsc782667
24. Akos040750655
25. Db12013
26. Nsc-782667
27. 3-((1r,3s,5s)-8-(2-((s)-n-(cyclohexylmethyl)-2,3-dihydroxypropanamido)ethyl)-8-azabicyclo[3.2.1]octan-3-yl)benzamide
28. Hy-16765
29. Cs-0012380
30. Ns00073321
31. P14961
32. 3-[(1r,5s)-8-[2-[cyclohexylmethyl-[(2s)-2,3-dihydroxypropanoyl]amino]ethyl]-8-azabicyclo[3.2.1]octan-3-yl]benzamide
33. 3-[(1s,5r)-8-[2-[cyclohexylmethyl-[(2s)-2,3-dihydroxypropanoyl]amino]ethyl]-8-azabicyclo[3.2.1]octan-3-yl]benzamide
| Molecular Weight | 457.6 g/mol |
|---|---|
| Molecular Formula | C26H39N3O4 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 107 |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 654 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
59
PharmaCompass offers a list of Axelopran API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Axelopran manufacturer or Axelopran supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Axelopran manufacturer or Axelopran supplier.
A Axelopran manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Axelopran, including repackagers and relabelers. The FDA regulates Axelopran manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Axelopran API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Axelopran supplier is an individual or a company that provides Axelopran active pharmaceutical ingredient (API) or Axelopran finished formulations upon request. The Axelopran suppliers may include Axelopran API manufacturers, exporters, distributors and traders.
Axelopran Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Axelopran GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Axelopran GMP manufacturer or Axelopran GMP API supplier for your needs.
A Axelopran CoA (Certificate of Analysis) is a formal document that attests to Axelopran's compliance with Axelopran specifications and serves as a tool for batch-level quality control.
Axelopran CoA mostly includes findings from lab analyses of a specific batch. For each Axelopran CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Axelopran may be tested according to a variety of international standards, such as European Pharmacopoeia (Axelopran EP), Axelopran JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Axelopran USP).
